Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study

Kirsten E Wiens1, Anita S Iyer2, Taufiqur R Bhuiyan3

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, PA, USA.

The Lancet. Microbe
|March 12, 2023
PubMed
Summary

New research reveals antibody-dependent complement deposition is a better predictor of cholera protection than vibriocidal antibodies. This finding could improve cholera vaccine development and efficacy assessments.